API swings to $23.3m loss
API swings to $23.3m loss
pharmaceuticals - News, Features, and Slideshows
News about pharmaceuticals
-
-
IDT Australia forecasts improved FY12 profit
Pharmaceutical manufacturer IDT Australia (ASX:IDT) expects an improved profit result in FY12, despite also projecting a 1H loss
-
Sigma swings to black in July half
Sigma Pharmaceuticals (ASX:SIP) swung to a $26.7m profit for the half year ending in July, but revenue was impacted by the loss of a wholesale deal
-
API reports $35.1m loss
API (ASX:API) recorded a $35.1m half-year loss after incurring impairment charges and costs from the Queensland floods, but said the disaster-related costs are recoverable through insurance
-
IBM set to lose megadeal with AstraZeneca
Global pharmaceuticals giant AstraZeneca, headquartered in London, is set to break off its IT outsourcing relationship with IBM, Computer Sweden and sister publication IT24 have learned.
Whitepapers about pharmaceuticals
-
Solving Desktop Management Problems
This infographic details the effects a new operating system that has solved desktop problems for more than 700,000 healthcare professionals, 1.8 million financial service users, 250,000 education users, over 300,000 pharmaceutical users and 1.7 million public sector users on more than 6 million end points.